Merck & Co., Inc. is 1.9x more valuable than ABBOTT LABORATORIES by market capitalization ($293.16 B vs $154.72 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | ABT | MRK |
|---|---|---|
| Market cap | $154.72 B | $293.16 B |
| US-listed rank | #96 | #44 |
| Revenue (latest FY) | $44.33B | $65.01B |
| Net income (latest FY) | $6.52B | $18.25B |
| Net margin | 14.7% | 28.1% |
| P/E (trailing FY) | 23.7 | 16.1 |
| SEC filings | 1,001 | 996 |
Merck & Co., Inc. is 1.9x more valuable than ABBOTT LABORATORIES by market capitalization ($293.16 B vs $154.72 B).
In their latest fiscal years, ABBOTT LABORATORIES reported $44.33B in revenue while Merck & Co., Inc. reported $65.01B.
Full pages: ABBOTT LABORATORIES and Merck & Co., Inc., or browse the full rankings.